Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Until human clinical trials validate BPC157s safety and effectiveness, and until regulatory bodies approve pharmaceutical-grade versions, it remains a biologically active but legally and clinically dicey regarding human injection
Unlike traditional growth hormone therapy, AOD-9604 does not significantly increase insulin-like growth factor-1 (IGF-1) or disrupt normal hormone levels
AOD9604 vs Intact hGH in Obesity Models A direct head-to-head comparison of AOD9604 and intact hGH in obese and lean mice confirmed that both compounds significantly reduced body weight gain in obese animals through increased fat oxidation and lipolysis stimulation but that AOD9604 achieved this without the hGH receptor binding, IGF-1 stimulation, hyperglycaemia, or reduced insulin secretion associated with full-length hGH treatment
If they inject it into a vein, the body may lose a high proportion as the person passes urine
it also counteracts the bleeding disorders, amputation, organ perforation, and/or anti-coagulants application or major vessel occlusion (Stupnisek et al., 2012
US$ 27.48
US$ 26.16
US$ 25.09
US$ 27.58
US$ 28.99
US$ 29.40
US$ 24.32
US$ 29.34
US$ 22.44
US$ 21.82
.webp)
US$ 23.23
US$ 20.60
US$ 28.19
